A citation-based method for searching scientific literature

Anupam Kotwal, Dana Erickson, Jennifer R Geske, Ian D Hay, M Regina Castro. Thyroid 2021
Times Cited: 12







List of co-cited articles
36 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
960
66

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing.
Raffaele Ciampi, Cristina Romei, Teresa Ramone, Alessandro Prete, Alessia Tacito, Virginia Cappagli, Valeria Bottici, David Viola, Liborio Torregrossa, Clara Ugolini,[...]. iScience 2019
55
25

Association between age and disease specific mortality in medullary thyroid cancer.
Zeyad T Sahli, Joseph K Canner, Martha A Zeiger, Aarti Mathur. Am J Surg 2021
7
42

Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997-2014: A Nationwide Study.
Jes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, Kirstine Stochholm, Per Løgstrup Poulsen, Åse Krogh Rasmussen, Ulla Feldt-Rasmussen, Sten Schytte, Stefano Christian Londero, Henrik Baymler Pedersen,[...]. Thyroid 2019
27
25

Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.
Reese W Randle, Courtney J Balentine, Glen E Leverson, Jeffrey A Havlena, Rebecca S Sippel, David F Schneider, Susan C Pitt. Surgery 2017
94
25


Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer.
Viktoria F Koehler, Pia Adam, Karin Frank-Raue, Friedhelm Raue, Elke Berg, Eva Hoster, Stephanie Allelein, Matthias Schott, Matthias Kroiss, Christine Spitzweg. Thyroid 2021
21
25


Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.
E Modigliani, R Cohen, J M Campos, B Conte-Devolx, B Maes, A Boneu, M Schlumberger, J C Bigorgne, P Dumontier, L Leclerc,[...]. Clin Endocrinol (Oxf) 1998
356
16


Clinico-pathologic and dynamic prognostic factors in sporadic and familial medullary thyroid carcinoma: an Israeli multi-center study.
Orit Twito, Simona Grozinsky-Glasberg, Sigal Levy, Gideon Bachar, David J Gross, Carlos Benbassat, Alon Rozental, Dania Hirsch. Eur J Endocrinol 2019
3
66

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Rossella Elisei, Barbara Cosci, Cristina Romei, Valeria Bottici, Giulia Renzini, Eleonora Molinaro, Laura Agate, Agnese Vivaldi, Pinuccia Faviana, Fulvio Basolo,[...]. J Clin Endocrinol Metab 2008
324
16


Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening.
Francesca Torresan, Caterina Mian, Elisabetta Cavedon, Maurizio Iacobone. Langenbecks Arch Surg 2019
10
20

Guidelines for diagnosis and therapy of MEN type 1 and type 2.
M L Brandi, R F Gagel, A Angeli, J P Bilezikian, P Beck-Peccoz, C Bordi, B Conte-Devolx, A Falchetti, R G Gheri, A Libroia,[...]. J Clin Endocrinol Metab 2001
16

Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
Kenko Cupisti, Achim Wolf, Andreas Raffel, Matthias Schott, Daniel Miersch, Qin Yang, Claus F Eisenberger, Hans D Röher, Wolfram T Knoefel. Ann Surg 2007
66
16

Prognostic significance and optimal cutoff of age in medullary thyroid cancer.
Ning Qu, Rong-Liang Shi, Ting-Xian Luo, Yu-Long Wang, Duan-Shu Li, Yu Wang, Cai-Ping Huang, Qing-Hai Ji. Oncotarget 2016
14
16

Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
Francesca Torresan, Elisabetta Cavedon, Caterina Mian, Maurizio Iacobone. World J Surg 2018
19
16

Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Hye-Seon Oh, Hyemi Kwon, Eyun Song, Min Ji Jeon, Dong Eun Song, Tae Yong Kim, Jeong Hyun Lee, Suck Joon Hong, Won Bae Kim, Young Kee Shong,[...]. Thyroid 2018
20
16



RAS proto-oncogene in medullary thyroid carcinoma.
Margarida M Moura, Branca M Cavaco, Valeriano Leite. Endocr Relat Cancer 2015
58
16

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.
Elaine T Lam, Matthew D Ringel, Richard T Kloos, Thomas W Prior, Michael V Knopp, Jiachao Liang, Steffen Sammet, Nathan C Hall, Paul E Wakely, Vasyl V Vasko,[...]. J Clin Oncol 2010
276
16

Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
Eric J Kuo, Shonan Sho, Ning Li, Kyle A Zanocco, Michael W Yeh, Masha J Livhits. JAMA Surg 2018
35
16


The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Tal Rozenblat, Dania Hirsch, Eyal Robenshtok, Simona Grozinsky-Glasberg, David J Gross, Haggi Mazeh, Carlos Benbassat, Orit Twito, Sigal Levy, Aviram Mizrachi,[...]. Eur J Surg Oncol 2020
10
20

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
Lori J Wirth, Eric Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen Lorch, Francis Worden, Marcia Brose, Jyoti Patel, Sophie Leboulleux,[...]. N Engl J Med 2020
192
16

Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations.
Rossella Elisei, Alessia Tacito, Teresa Ramone, Raffaele Ciampi, Valeria Bottici, Virginia Cappagli, David Viola, Antonio Matrone, Loredana Lorusso, Laura Valerio,[...]. Genes (Basel) 2019
27
16

Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Andreas Machens, Kerstin Lorenz, Frank Weber, Henning Dralle. J Clin Endocrinol Metab 2021
7
28

Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
Mohamed Abdelgadir Adam, Samantha Thomas, Sanziana A Roman, Terry Hyslop, Julie A Sosa. JAMA Surg 2017
37
16

Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome.
Bayan Alzumaili, Bin Xu, Philip M Spanheimer, R Michael Tuttle, Eric Sherman, Nora Katabi, Snjezana Dogan, Ian Ganly, Brian R Untch, Ronald A Ghossein. Mod Pathol 2020
15
16

Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study.
Jes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, Per Løgstrup Poulsen, Åse Krogh Rasmussen, Ulla Feldt-Rasmussen, Sten Schytte, Stefano Christian Londero, Henrik Baymler Pedersen, Christoffer Holst Hahn,[...]. Endocr Connect 2019
5
40

American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.
Robert C Smallridge, Kenneth B Ain, Sylvia L Asa, Keith C Bible, James D Brierley, Kenneth D Burman, Electron Kebebew, Nancy Y Lee, Yuri E Nikiforov, M Sara Rosenthal,[...]. Thyroid 2012
439
16

Thyroid cancer.
Maria E Cabanillas, David G McFadden, Cosimo Durante. Lancet 2016
617
16

Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative "marker" for lymph node metastases.
Christian Scheuba, Klaus Kaserer, Klaus Kaczirek, Reza Asari, Bruno Niederle. World J Surg 2006
35
16

Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
Andreas Machens, Henning Dralle. J Clin Endocrinol Metab 2010
158
16


Incidence of Thyroid Function Test Abnormalities in Patients Receiving Immune-Checkpoint Inhibitors for Cancer Treatment.
Nisha Subhash Patel, Anais Oury, Gregory A Daniels, Lyudmila Bazhenova, Sandip Pravin Patel. Oncologist 2018
13
8

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma.
Jeffrey Weber, John A Thompson, Omid Hamid, David Minor, Asim Amin, Ilan Ron, Ruggero Ridolfi, Hazem Assi, Anthony Maraveyas, David Berman,[...]. Clin Cancer Res 2009
425
8

The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition.
Gilda Varricchi, Stefania Loffredo, Giancarlo Marone, Luca Modestino, Poupak Fallahi, Silvia Martina Ferrari, Amato de Paulis, Alessandro Antonelli, Maria Rosaria Galdiero. Int J Mol Sci 2019
43
8

THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW.
Mazen Al Mushref, Paul A Guido, Frances A Collichio, Dominic T Moore, David R Clemmons. Endocr Pract 2020
16
8

Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.
Jeffrey S Weber, Geoff Gibney, Ryan J Sullivan, Jeffrey A Sosman, Craig L Slingluff, Donald P Lawrence, Theodore F Logan, Lynn M Schuchter, Suresh Nair, Leslie Fecher,[...]. Lancet Oncol 2016
229
8

Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma.
Alexander T Faje, Ryan Sullivan, Donald Lawrence, Nicholas A Tritos, Riley Fadden, Anne Klibanski, Lisa Nachtigall. J Clin Endocrinol Metab 2014
247
8

Thyroid dysfunctions secondary to cancer immunotherapy.
P Chalan, G Di Dalmazi, F Pani, A De Remigis, A Corsello, P Caturegli. J Endocrinol Invest 2018
34
8

Immune modulation in cancer with antibodies.
David B Page, Michael A Postow, Margaret K Callahan, James P Allison, Jedd D Wolchok. Annu Rev Med 2014
351
8


Enhancing SIV-specific immunity in vivo by PD-1 blockade.
Vijayakumar Velu, Kehmia Titanji, Baogong Zhu, Sajid Husain, Annette Pladevega, Lilin Lai, Thomas H Vanderford, Lakshmi Chennareddi, Guido Silvestri, Gordon J Freeman,[...]. Nature 2009
579
8

Thyroid disorders induced by checkpoint inhibitors.
Silvia Martina Ferrari, Poupak Fallahi, Fabio Galetta, Emanuele Citi, Salvatore Benvenga, Alessandro Antonelli. Rev Endocr Metab Disord 2018
49
8

Incidence of thyroid dysfunctions during treatment with nivolumab for non-small cell lung cancer: Retrospective study of 105 patients.
Pauline Campredon, Céline Mouly, Amélie Lusque, Laurence Bigay-Game, Emilie Bousquet, Julien Mazières, Philippe Caron. Presse Med 2019
17
8

Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.
Meng H Tan, Ravi Iyengar, Kara Mizokami-Stout, Sarah Yentz, Mark P MacEachern, Li Yan Shen, Bruce Redman, Roma Gianchandani. Clin Diabetes Endocrinol 2019
71
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.